HIGHLIGHTS
- who: Daniel Butler from the Department of Microbiology, Immunology and Glycobiology, Institute of Laboratory Medicine, Lund University, Lund, Sweden have published the research: Immunomodulation therapy offers new molecular strategies to treat UTI, in the Journal: (JOURNAL) of 22/06/2022
- what: This Review highlights the importance of innate immune control in UTI and the potential of innate immunomodulation therapy to target u2018bad inflammation` as a cause of disease.
- how: The broad MMP inhibitor batimastat (also known as BB-94) was tested for therapeutic efficacy using the same protocol as for IL-1RA treatment12 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.